In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease

The COVID-19 pandemic has caused severe health threat globally, and novel SARS-Cov-2 inhibitors are urgently needed for antiviral treatment. The main protease (M<sup>pro</sup>) of the virus is one of the most effective and conserved targets for anti-SARS-CoV-2 drug development. In this s...

Full description

Bibliographic Details
Main Authors:	Menghan Gao, Dongwei Kang, Na Liu, Yanna Liu
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Molecules
Subjects:	SARS-CoV-2 main protease inhibitors molecular docking-based virtual screening MD simulation
Online Access:	https://www.mdpi.com/1420-3049/28/14/5320

Similar Items

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-06-01)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
by: Vishma Pratap Sur, et al.
Published: (2021-10-01)

Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
by: Bodee Nutho, et al.
Published: (2022-01-01)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01)

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease
by: Alexander M. Andrianov, et al.
Published: (2023-04-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus <i>Aloe</i>: An In Silico Study for Drug Development
by: Mohamed E. Abouelela, et al.
Published: (2021-03-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022-10-01)

Insights into the structural properties of SARS-CoV-2 main protease
by: Ibrahim Yagiz Akbayrak, et al.
Published: (2022-01-01)

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library
by: Nanxin Liu, et al.
Published: (2023-07-01)

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Inhibitors
by: Mahmoud A. A. Ibrahim, et al.
Published: (2021-04-01)

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Eslam B. Elkaeed, et al.
Published: (2022-07-01)

Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease
by: Balasubramanian Moovarkumudalvan, et al.
Published: (2022-11-01)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
by: Wenfa Zhang, et al.
Published: (2023-02-01)

In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
by: Elham Aghaee, et al.
Published: (2021-01-01)

Cotton flower metabolites inhibit SARS‐CoV‐2 main protease
by: Yufang Zhang, et al.
Published: (2022-10-01)

Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification
by: EBENEZER OLUWAKEMI, et al.
Published: (2022-06-01)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
by: Željko Reiner, et al.
Published: (2020-04-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel <i>In Silico</i> Method
by: Milan Sencanski, et al.
Published: (2020-08-01)

In silico analysis of selected components of grapefruit seed extract against SARS-CoV-2 main protease
by: Saric Belmina, et al.
Published: (2021-06-01)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020-11-01)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
by: Annamaria Martorana, et al.
Published: (2020-07-01)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
by: Hu Wang, et al.
Published: (2022-11-01)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
by: Panthakarn Rangsinth, et al.
Published: (2021-03-01)

Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
by: Aniruddhya Mukherjee, et al.
Published: (2023-07-01)

In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
by: Tien Huynh, et al.
Published: (2021-02-01)

Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters
by: Fangya Li, et al.
Published: (2023-06-01)

Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
by: Nedra Mekni, et al.
Published: (2021-07-01)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
by: Thrigulla Saketh Ram, et al.
Published: (2022-01-01)

In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
by: Bala Mohan Sivani, et al.
Published: (2021-01-01)

In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
by: Seyyed Sasan Mousavi, et al.
Published: (2021-09-01)

Identification of Potential Natural Bioactive Compounds from Glycyrrhiza glabra as Sars-CoV-2 Main Protease (MPRO) Inhibitors: In-Silico Approach
by: Ashraf A. A. Abdusalam, et al.
Published: (2022-06-01)

Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study
by: Ishola Abeeb Akinwumi, et al.
Published: (2023-12-01)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
by: Pandu Hariyono, et al.
Published: (2022-01-01)

Noncovalent SARS-COV-2 main protease inhibitors: A virtual screening and molecular dynamic simulation study
by: Aoxiang Yan, et al.
Published: (2024-01-01)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
by: Sobia Ahsan Halim, et al.
Published: (2021-09-01)

Polyphenols as alternative treatments of COVID-19
by: Yifei Wu, et al.
Published: (2021-01-01)

In silico identification of drug candidates against COVID-19
by: Yifei Wu, et al.
Published: (2020-01-01)